Navigation Links
Benefit of targeted lung cancer therapy confirmed
Date:6/3/2011

AURORA, Colo. (June 3, 2011) A drug that targets a specific type of lung cancer shows a dramatic response in more than half of the people who take it. The drug, called crizotinib, has been in clinical trials since 2006, and the results from the largest group of patients to take it within the first of these clinical trials are being presented at the annual meeting of the American Society of Clinical Oncology (ASCO).

The patients taking crizotinib have anaplastic lymphoma kinase (ALK) positive advanced non-small cell lung cancer (NSCLC) and the drug targets the gene that drives this particular kind of cancer. In 119 patients, crizotinib produces some degree of shrinkage in the tumors of the majority of patients with dramatic responses in more than 60 percent of cases. The responses last approximately 48 weeks.

D. Ross Camidge, MD, PhD, the director of the lung cancer clinical program at University of Colorado Hospital (UCH) and the University of Colorado Cancer Center, will be presenting the latest results from the crizotinib trial at ASCO. "The strength of crizotinib in ALK positive lung cancer was apparent when less than 20 patients were taking part in the trial. The benefit of targeting this kind of cancer with this particular drug has only been confirmed as more patients enrolled in the trial," said Camidge. "This demonstrates the efficacy of new drugs can be reliably revealed even among small groups of patients when the cancers being tested are molecularly uniform."

Medical oncologists at UCH care for one of the largest groups of ALK positive lung cancer patients in the world. Approximately one in 20 lung cancer patients is ALK positive - their responses to crizotinib are dramatic, the side effects are usually mild and often improve over time.

Camidge believes the results being seen with crizotinib open the door to a new way of thinking when it comes to cancer treatment. "We need to continue testing drugs in mole
'/>"/>

Contact: Erika Matich
erika.matich@ucdenver.edu
720-848-7852
University of Colorado Denver
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Mechanism discovered for health benefit of green tea, new approach to autoimmune disease
2. Radiology benefit managers adversely affect referring physicians, study suggests
3. Acupuncture of benefit to those with unexplained symptoms
4. Trial Stopped After Niacin Brings No Benefit to Heart Patients
5. CT angiography for low-risk heart patients leads to more drugs and tests without benefit
6. CT Heart Scans No Benefit to Patients Without Symptoms
7. Cancer Patients Benefit From Full Access to Medical Records
8. Enlarged prostate: Study demonstrates immediate and long-term benefits of laser treatment
9. Half of prostate cancers could potentially benefit from new type of cancer drugs, U-M study finds
10. Hospitals misleading patients about benefits of robotic surgery, study suggests
11. Selenium Supplements Might Give Modest Benefit Against Cholesterol
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... strongly associated with Alzheimer,s disease; however, researchers are still ... causal agent of the onset and development of the ... beta-amyloid is not harmful when found in isolation but ... to form the so-called amyloid fibrils , "We are ... with multiple ones because each aggregate of peptide, which ...
(Date:10/1/2014)... October 1, 2014 Patients with increased inflammation, ... a greatly increased risk of depression. For example, ... chronic hepatitis C virus infection causes depression in ... acids, more commonly known as fish oil, have ... the risk of heart disease and reducing triglyceride ...
(Date:10/1/2014)... 01, 2014 Insuranceragents.info has released ... good life insurance plan for vulnerable family members. , ... family members. Providers in the family should always carry ... financial hardships for the rest of the family. ... Families can benefit more from temporary coverage or from ...
(Date:10/1/2014)... ATLANTA (PRWEB) October 01, 2014 ... executive networking and relationship-marketing firm, announced today ... Security Executive® and Project of the Year ... decision makers representing organizations in financial services, ... include large-scale technology endeavors that address key ...
(Date:10/1/2014)... 01, 2014 Between 23 million and ... U.S., according to figures from the National Institutes of ... (AARDA), and many of them have something else in ... undiagnosed celiac disease. Gluten Free Therapeutics, makers of ... undiagnosed celiac disease by publishing a series of blog ...
Breaking Medicine News(10 mins):Health News:Laying siege to beta-amyloid, the key protein in Alzheimer's disease 2Health News:Omega-3 fatty acids may prevent some forms of depression 2Health News:Life Insurance for Families - Clients Can Compare Affordable Rates Online! 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 3Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 4Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 5Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 6Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 7Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 3
... announced a pre-approval program to compliment the Small Business Administration,s recent ... remove fees charged to banks and make it easier for entrepreneurs ... ... St. Louis, MO (PRWEB) April 7, 2009 -- Health Career ...
... April 7 Leading Sucralose manufacturer Guangdong Food ... announced that the U.S. International Trade Commission (ITC) ... a Section 337 patent dispute (docket no. 337-TA-604) ... & Lyle Corporation (T&L). Mr. Wang Sanyong, ...
... Acupuncture cannot be shown to have any positive effect on ... a systematic review of literature by three groups in Daejon, ... edition of the peer-reviewed journal Climacteric . , Many ... use, but still have to deal with the symptoms which ...
... of corporate training software and solutions, has partnered with Medcom ... courses to CERTPOINTVLS™ users. , ... ... provider of corporate training software and solutions, today announced they ...
... Inc., a global provider of image management services for biopharmaceutical and ... an agreement with AG Mednet, a HIPAA and 21 CFR Part ... to offer clinical trial sponsors more options for efficient, cost-effective image ... ...
... software to an assisted medical billing process providing the medical ... ... (Vocus) April 7, 2009 -- Glenwood Systems LLC announced today the ... efficiencies and improve physician revenue in an office based medical practice. ...
Cached Medicine News:Health News:Health Career Agents Announces SBA Pre-Approval Program to Launch a Healthcare Recruiting Business 2Health News:Health Career Agents Announces SBA Pre-Approval Program to Launch a Healthcare Recruiting Business 3Health News:GDFII/L&P Sucralose Win Over Competitor Tate & Lyle 2Health News:GDFII/L&P Sucralose Win Over Competitor Tate & Lyle 3Health News:Acupuncture 'probably ineffective' in treatment of hot flushes 2Health News:CERTPOINT Systems Partners with Medcom Trainex, Inc. to Offer Extensive Library of Healthcare Courses -- Professionals in Healthcare sector to benefit from online educational courses 2Health News:CERTPOINT Systems Partners with Medcom Trainex, Inc. to Offer Extensive Library of Healthcare Courses -- Professionals in Healthcare sector to benefit from online educational courses 3Health News:CERTPOINT Systems Partners with Medcom Trainex, Inc. to Offer Extensive Library of Healthcare Courses -- Professionals in Healthcare sector to benefit from online educational courses 4Health News:M2S Announces Agreement with AG Mednet to Provide Clinical Trial Sponsors with More Options for Efficient Image Transfer and Collection 2Health News:M2S Announces Agreement with AG Mednet to Provide Clinical Trial Sponsors with More Options for Efficient Image Transfer and Collection 3Health News:Glenwood Systems, LLC Releases EMR Practice Management and Medical Billing Process Improvement Program 2Health News:Glenwood Systems, LLC Releases EMR Practice Management and Medical Billing Process Improvement Program 3
(Date:10/1/2014)... , Oct. 1, 2014 ... now available. Interested parties can learn about ... Cardinal Health is supporting the health care ... http://cardinalhealth.com/annualreport . Photo- http://photos.prnewswire.com/prnh/20140930/149504-INFO ... summary financials and the chief executive officer,s ...
(Date:10/1/2014)... , Oct. 1, 2014  Dyadic International, ... with patented and proprietary technology used to develop ... bioenergy, bio-based chemicals, biopharmaceuticals, and industrial enzymes industries, ... payment from Abengoa Bioenergy for commercial scale production ... biomass into ethanol, developed under Abengoa,s license agreement ...
(Date:10/1/2014)... , Oct. 1, 2014  ResMed (NYSE: ... and the first company to design complete sleep apnea solutions ... women about the importance of a good night,s sleep. ... challenge the myth that feeling tired is just part of ... that sleep is a critical pillar of health, essential to ...
Breaking Medicine Technology:Cardinal Health 2014 Digital Report to Shareholders Now Available 2Dyadic International Reports Licensing Payment For Commercial-Scale Production Of C1-Based Cellulase Enzymes 2Dyadic International Reports Licensing Payment For Commercial-Scale Production Of C1-Based Cellulase Enzymes 3ResMed Launches Initiative to Help Women Get Better Sleep 2ResMed Launches Initiative to Help Women Get Better Sleep 3
... LONDON, Nov. 11, 2010 UK based Trimega Laboratories is ... met the standards set by the prestigious Investors in People ... by the Employer Representative Quality Board of IIP and reflects ... an organization. A significant aspect of the achievement is that, ...
... Inc. (OTCQB: ILIU) today announced financial and operational results for ... for the three months ended September 30, 2010 was $0.5 ... the prior year. The increase was primarily attributable to greater ... Research and development expenses were $0.4 million for the three ...
Cached Medicine Technology:IIP Recognition for Substance Abuse Testing Lab Trimega Laboratories 2Interleukin Genetics Reports Third Quarter 2010 Financial Results 2Interleukin Genetics Reports Third Quarter 2010 Financial Results 3Interleukin Genetics Reports Third Quarter 2010 Financial Results 4Interleukin Genetics Reports Third Quarter 2010 Financial Results 5
Two point fixation, tips separated by 13 mm. Each tip has 0.12 mm, 1 x 2 teeth. Wide serrated handle with thumb catch lock and dull finish....
Magnetic Farnsworth D15 kit Magnets move the color disks. Protects disks from fingerprints. Keeps all the disks in one place. Clear glass insures accurate color perception. Makes color testing fun....
... the Farnsworth-Munsell 100 Hue Test. It is intended ... study of a color vision defect. It provides ... difficulty in distinguishing color differences in certain tasks. ... reference caps with Munsell notations, plus a neutral ...
Spanish HRR/Amsler combination with Spanish and English directions for both HRR and amsler tests plus occluding glasses....
Medicine Products: